_version_ 1784705047795335168
author Lozano‐Rodríguez, Roberto
Terrón‐Arcos, Verónica
Montalbán‐Hernández, Karla
Casalvilla‐Dueñas, José Carlos
Bergón‐Gutierrez, Marta
Pascual‐Iglesias, Alejandro
Quiroga, Jaime Valentín
Aguirre, Luis A.
Pérez de Diego, Rebeca
Vela‐Olmo, Carmen
López‐Morejón, Lissette
Martín‐Quirós, Alejandro
del Balzo‐Castillo, Álvaro
Peinado‐Quesada, María A.
García‐Garrido, Miguel A.
Gómez‐Lage, Laura
Herrero‐Benito, Carmen
Llorente‐Fernández, Irene
Martín‐Miguel, Gema
Torrejón, Margarita
Cubillos‐Zapata, Carolina
del Fresno, Carlos
Avendaño‐Ortiz, José
López‐Collazo, Eduardo
author_facet Lozano‐Rodríguez, Roberto
Terrón‐Arcos, Verónica
Montalbán‐Hernández, Karla
Casalvilla‐Dueñas, José Carlos
Bergón‐Gutierrez, Marta
Pascual‐Iglesias, Alejandro
Quiroga, Jaime Valentín
Aguirre, Luis A.
Pérez de Diego, Rebeca
Vela‐Olmo, Carmen
López‐Morejón, Lissette
Martín‐Quirós, Alejandro
del Balzo‐Castillo, Álvaro
Peinado‐Quesada, María A.
García‐Garrido, Miguel A.
Gómez‐Lage, Laura
Herrero‐Benito, Carmen
Llorente‐Fernández, Irene
Martín‐Miguel, Gema
Torrejón, Margarita
Cubillos‐Zapata, Carolina
del Fresno, Carlos
Avendaño‐Ortiz, José
López‐Collazo, Eduardo
author_sort Lozano‐Rodríguez, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-9092002
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90920022022-05-16 Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study Lozano‐Rodríguez, Roberto Terrón‐Arcos, Verónica Montalbán‐Hernández, Karla Casalvilla‐Dueñas, José Carlos Bergón‐Gutierrez, Marta Pascual‐Iglesias, Alejandro Quiroga, Jaime Valentín Aguirre, Luis A. Pérez de Diego, Rebeca Vela‐Olmo, Carmen López‐Morejón, Lissette Martín‐Quirós, Alejandro del Balzo‐Castillo, Álvaro Peinado‐Quesada, María A. García‐Garrido, Miguel A. Gómez‐Lage, Laura Herrero‐Benito, Carmen Llorente‐Fernández, Irene Martín‐Miguel, Gema Torrejón, Margarita Cubillos‐Zapata, Carolina del Fresno, Carlos Avendaño‐Ortiz, José López‐Collazo, Eduardo Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2022-05-11 /pmc/articles/PMC9092002/ /pubmed/35538923 http://dx.doi.org/10.1002/ctm2.869 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Lozano‐Rodríguez, Roberto
Terrón‐Arcos, Verónica
Montalbán‐Hernández, Karla
Casalvilla‐Dueñas, José Carlos
Bergón‐Gutierrez, Marta
Pascual‐Iglesias, Alejandro
Quiroga, Jaime Valentín
Aguirre, Luis A.
Pérez de Diego, Rebeca
Vela‐Olmo, Carmen
López‐Morejón, Lissette
Martín‐Quirós, Alejandro
del Balzo‐Castillo, Álvaro
Peinado‐Quesada, María A.
García‐Garrido, Miguel A.
Gómez‐Lage, Laura
Herrero‐Benito, Carmen
Llorente‐Fernández, Irene
Martín‐Miguel, Gema
Torrejón, Margarita
Cubillos‐Zapata, Carolina
del Fresno, Carlos
Avendaño‐Ortiz, José
López‐Collazo, Eduardo
Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title_full Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title_fullStr Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title_full_unstemmed Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title_short Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
title_sort prior sars‐cov‐2 infection balances immune responses triggered by four ema‐approved covid‐19 vaccines: an observational study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092002/
https://www.ncbi.nlm.nih.gov/pubmed/35538923
http://dx.doi.org/10.1002/ctm2.869
work_keys_str_mv AT lozanorodriguezroberto priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT terronarcosveronica priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT montalbanhernandezkarla priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT casalvilladuenasjosecarlos priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT bergongutierrezmarta priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT pascualiglesiasalejandro priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT quirogajaimevalentin priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT aguirreluisa priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT perezdediegorebeca priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT velaolmocarmen priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT lopezmorejonlissette priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT martinquirosalejandro priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT delbalzocastilloalvaro priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT peinadoquesadamariaa priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT garciagarridomiguela priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT gomezlagelaura priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT herrerobenitocarmen priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT llorentefernandezirene priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT martinmiguelgema priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT torrejonmargarita priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT cubilloszapatacarolina priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT delfresnocarlos priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT avendanoortizjose priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy
AT lopezcollazoeduardo priorsarscov2infectionbalancesimmuneresponsestriggeredbyfouremaapprovedcovid19vaccinesanobservationalstudy